1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61064BB40E51E97A4852584820045B61F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-value-driven-patient-support-programs-partnerships-patient-support-hubs-best-practices-pitfalls?opendocument
18
19opendocument
2018.97.14.80
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Patient Focused Services » Patient Support Programs

Value-Driven Patient Support Programs: Partnerships, Patient Support Hubs, Best Practices and Pitfalls

ID: 5582


Features:

5 Info Graphics

12 Data Graphics

115+ Metrics

7 Narratives


Pages/Slides: 25


Published: Pre-2020


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Value-Driven Patient Support Programs: Partnerships, Patient Support Hubs, Best Practices and Pitfalls”

STUDY OVERVIEW

As the healthcare industry gravitates toward increased patient centricity, pharmaceutical organizations are taking rapid steps to improve the effectiveness of their patient support programs.

However, in this new and challenging environment, patient support programs have evolved beyond just providing financial assistance for patients' medications. It is, therefore, important for organizations to develop a comprehensive strategy to effectively engage patients and improve outcomes.

Best Practices, LLC conducted this benchmarking research to better understand the growing importance of establishing a patient centric organization and how it can positively impact patient outcomes and commercial results. This study delivers insights around internal and external partnerships, and implementing patient support hubs. It also identifies the best practices and pitfalls encountered in maintaining an effective Patient Support organization.

Patient support leaders can use this study to compare how their patient support programs stack up against industry averages and trends.

KEY TOPICS

  • Involvement Level of Legal Department in Patient Support Activities
  • Vendor Management
  • Patient Support Hub Services
  • Tailoring of Patient Support Programs
  • Best Practices in Maintaining an Effective Patient Support Organization
  • Critical Pitfalls

KEY METRICS
  • What is the level of legal department involvement in patient support activities?
  • Do you utilize patient hub services as part of your patient support activities?
  • Is your patient support hub operation performed in-house or through a vendor?
  • What do you include in your packages / services?
  • What factors do you consider when tailoring programs for patients?
  • Which type of hub IT platform do you use?
  • Please share best practices for maintaining an effective patient support organization
  • Please list pitfalls or stumbling blocks that you've observed as part of a patient support organization

SAMPLE KEY FINDINGS
  • Consider practical needs around treatments while tailoring programs: All participants take into account practical needs around treatments while tailoring patient support programs. Financial indicators (78%), emotional needs (67%), and medical unmet needs (56%) are also considered by most participants.

METHODOLOGY

Best Practices, LLC engaged 57 Patient Support leaders from 41 pharmaceutical companies in this research through a primary benchmarking survey. Research analysts also conducted secondary research regarding the different platforms that companies are using to engage with patients. More than 70% of the benchmark partners serve at the director level or above.


Industries Profiled:
Pharmaceutical; Biopharmaceutical; Medical Device; Manufacturing; Biotech; Consumer Products; Diagnostic; Service; Chemical; Health Care; Communications; Research; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Alexion Pharmaceuticals; Alkermes; Astellas; AstraZeneca; Baxter International; Bayer; Bionical Solutions; Boehringer Ingelheim; Celgene; Cipla; Daiichi Sankyo; Dr Reddy's Laboratories; EMD Serono; Envision Pharma Group; GlaxoSmithKline ; Hoffmann-La Roche; Horizon Pharma; Incyte; Invive Healthcare; Ipsen; Johnson & Johnson; Kadmon Pharmaceuticals; LEO Pharma; Merck; Merck Serono; MSD; Myovant Sciences; NexGen Healthcare Communications; Novartis; Novo Nordisk; OTSUKA; Parexel; Pfizer; S3 Group; Sanofi; Sanofi Genzyme; Servier; Takeda Oncology; Takeda Pharmaceuticals; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.